CAPTRUST FINANCIAL ADVISORS - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$10,000
+42.9%
58
+9.4%
0.00%
Q2 2021$7,0000.0%53
+3.9%
0.00%
Q1 2021$7,00051
+1600.0%
0.00%
Q2 2018$030.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,080,113$50,301,0004.98%
Foresite Capital Management II, LLC 188,602$8,783,0003.96%
Artal Group S.A. 1,650,000$76,841,0003.14%
Foresite Capital Management III, LLC 254,923$11,872,0003.09%
Asymmetry Capital Management, L.P. 30,125$1,403,0002.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,255,174$58,453,0002.24%
QVT Financial LP 190,977$8,894,0002.24%
SECTORAL ASSET MANAGEMENT INC 269,396$12,546,0001.51%
Novo Holdings A/S 198,261$9,233,0001.37%
FARALLON CAPITAL MANAGEMENT LLC 2,375,000$110,604,0000.83%
View complete list of ACCELERON PHARMA INC shareholders